3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
19
Lymphoma, Follicular
18
Lymphoma, Mantle-Cell
17
Leukemia, Lymphocytic, Chronic, B-Cell
15
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma, B-Cell, Marginal Zone
10
Lymphoma, B-Cell
10
Lymphoma, Non-Hodgkin
9
Recurrence
6
Hodgkin Disease
6
Waldenstrom Macroglobulinemia
5
Neoplasms
3
Multiple Myeloma
3
Leukemia
3
Burkitt Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphatic Diseases
2
Leukemia, Hairy Cell
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Sezary Syndrome
1
Proteostasis Deficiencies
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Neurotoxicity Syndromes
1
Neoplasms, Plasma Cell
1
Neoplasm, Residual
1
Interventions
rasburicase
1
Uric Acid
1
Urate Oxidase
1
Pegloticase
1
Oxidoreductases
1
Carbamates
1
Amides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Tumor Lysis Syndrome
×
Bendamustine Hydrochloride
×
1 year
×
Clear all
No trials found.